Warning: mkdir(): Permission denied in /home/virtual/lib/view_data.php on line 87 Warning: chmod() expects exactly 2 parameters, 3 given in /home/virtual/lib/view_data.php on line 88 Warning: fopen(/home/virtual/e-kjs/journal/upload/ip_log/ip_log_2024-07.txt): failed to open stream: No such file or directory in /home/virtual/lib/view_data.php on line 95 Warning: fwrite() expects parameter 1 to be resource, boolean given in /home/virtual/lib/view_data.php on line 96 Knockdown of best1 Gene in Zebrafish Caused Abnormal Neuronal and Skeletal Development - A Subtype of Craniovertebral Junction Malformation?
Neurospine Search


Neurospine > Volume 21(2); 2024 > Article
Liu, Li, Wang, Zhang, Jia, Wang, Jian, and Wu: Knockdown of best1 Gene in Zebrafish Caused Abnormal Neuronal and Skeletal Development - A Subtype of Craniovertebral Junction Malformation?



To investigate the developmental defects caused by knockdown of best1 gene in zebrafish as a model for a subtype of craniovertebral junction (CVJ) malformation.


Two antisense morpholinos (MOs) were designed targeting zebrafish best1 to block translation (ATG-MO) or to disrupt splicing (I3E4-MO). MOs were microinjected into fertilized one-cell embryos. Efficacy of splicing MO was confirmed by reverse transcription-polymerase chain reaction. Phenotypes were analyzed and quantified by microscopy at multiple developmental stages. Neuronal outgrowth was assessed in transgenic zebrafish expressing green fluorescent protein in neurons. Skeletal ossification was visualized by Calcein staining.


Knockdown of best1 resulted in zebrafish embryos with shorter body length, curved axis, low survival rate, microcephaly, reduced eye size, smaller head and brain, impaired neuronal outgrowth, and reduced ossification of craniofacial and vertebral bone.


Best1 gene plays critical roles in ophthalmologic, neurological and skeletal development in zebrafish. A patient with a premature stop codon in BEST1 gene exhibited similar phenotypes, implying a subtype of CVJ malformation.


The craniovertebral junction (CVJ) is a highly complex functional unit consisting of the base of the occipital bone, the atlas (C1), the axis (C2) and the soft tissues around these skeletal structures [1,2]. It provides complex motion of upper cervical region and protects the crucial aera of the brainstem and upper cervical spinal cord. CVJ skeletal malformation can result in structural instability causing spectrum of neurological deficits including sensory and motion dysfunction, or even life-threatening dyspnea and cardiac arrest [3]. The spectrum of CVJ malformation includes atlantooccipital fusion, atlantoaxial dislocation, basilar invagination, platybasia, and vertebral artery variations [4]. It is intuitive to attribute the etiology of CVJ malformation to disturbance of embryonic development. Both genetic and environmental factors can be involved. Homeobox (HOX) genes are pivotal genetic regulators of embryonic axial development [2]. For instance, inactivating Hoxd3 in mice causes abnormal fusion of the atlas vertebra and the occiput, which is homologous to atlantooccipital fusion in human [5]. However, the genetic causes for the CVJ malformation were largely unclear.
Several studies suggested genetic predisposition underlying CVJ malformation. CVJ malformation has been reported to be much more common in Down syndrome (MIM: 190685) [6-8], Mucopolysaccharidosis type IVA (MIM: 253000) [9], and Wiedemann-Steiner syndrome (MIM: 605130) [10]. Sadler et al. [11] found that chromodomain (CHD) genes were associated with Chiari I malformation. Chauhan et al. [12] reported mutations in the FBN1 gene may play a part in CVJ malformation. In the previous study, we performed exome sequencing on 92 sporadic CVJ malformation patients and found damaging mutations of the BEST1 gene were significantly enriched in the patient group (p = 5.8× 10-6) [13]. Variants in BEST1 are associated with autosomal dominant vitelliform macular dystrophy-2 (VMD2 [MIM: 153700]) [14,15]. Inhibition of BEST1 resulted in an enhanced neuronal excitability in the cerebellum [16]. These studies indicated a disease-causing role of BEST1 gene mutations for eyeball, central nervous system, and maybe skeletal system disorders.
Given that the BEST1 gene is highly conserved in zebrafish and human, and zebrafish has been proven to be suitable for the study of human skeletal disease [17-19], we designed best1 morpholinos (MOs) and performed knockdown studies to investigate the role of best1 gene in early zebrafish development.


1. Zebrafish Care and Maintenance

Adult wild-type AB strain zebrafish were maintained at 28.5°C on a 14-hour light/10-hour dark cycle [20]. Five to 6 pairs of zebrafish were set up for natural mating every time. On average, 200–300 embryos were generated. Embryos were maintained at 28.5°C in fish water (0.2% Instant Ocean Salt in deionized water). The embryos were washed and staged according to Kimmel et al. [21]. The establishment and characterization of HuC-EGFP transgenic lines has been described elsewhere [22]. The zebrafish facility at SMOC (Shanghai Model Organisms Center, Inc., Shanghai, China) is accredited by the AAALAC (Association for Assessment and Accreditation of Laboratory Animal Care) International.

2. Zebrafish Microinjections and Phenotyping

It is imperative to identify a sequence within the best1 gene that is pivotal for its physiological function. We also avoid regions with high sequence homology to other genes, to reduce the chance of off-target effects. Gene Tools, LLC (http://www.gene-tools.com/) designed the MOs. Antisense MOs (GeneTools) were microinjected into fertilized one-cell stage embryos according to standard protocols [23]. The sequences of the best1 translation-blocking and splice-blocking MOs were 5′-CTGCGGGAGAGTCCAAAACACTTCA-3′ (ATG-MO) and 5′-GAGTACGTCACCGTCATCACTG-3′ (I3E4-MO), respectively. The sequence for the standard control-MO was 5′-CCTCTTACCTCAGTTACAATTTATA-3′ (Gene Tools). The amount of the MOs used for injection was as follows: Control-MO and I3E4-MO, 4 ng per embryo; ATG-MO, 4 ng per embryo. Primers spanning best1 exon 3 (forward primer: 5′-GCAGATGAAGGAGCCAGACT-3′) and exon 6 (reverse primer: 5′-AAACTGCCGACCAATCAGAC-3′) were used for reverse transcription-polymerase chain reaction (RT-PCR) analysis for confirmation of the efficacy of the I3E4-MO. The primer ef1α sequences used as the internal control were 5′-GGAAATTCGAGACCAGCAAATAC-3′ (forward) and 5′-GATACCAGCCTCAAACTCACC-3′ (reverse). At 2-dpf and 5-dpf, embryos were anesthetized with 0.016% MS-222 (tricaine methanesulfonate, Sigma-Aldrich, St. Louis, MO, USA). Zebrafish were then oriented on lateral side (anterior, left; posterior, right; dorsal, top), and mounted with 3% methylcellulose in a depression slide for observation by fluorescence microscopy. The phenotypes of gross morphology were quantified analyzed.

3. Quantitative Real-Time PCR

Total RNA was extracted from 20 to 30 embryos per group with Trizol (Roche, Basel, Switzerland) according to the manufacturer’s instructions. RNA was reverse transcribed using the the PrimeScript RT reagent Kit with gDNA Eraser (Takara, Tokyo, Japan). Quantification of gene expression was performed in triplicates using Bio-rad iQ SYBR Green Supermix (Bio-Rad Laboratories Inc., Hercules, CO, USA) with detection on the Realplex system (Eppendorf Co., Enfield, CT, USA). Relative gene expression quantification was based on the comparative threshold cycle method (2−ΔΔCt) using ef1α as endogenous control gene. Primer sequences are listed in Supplementary Table 1.

4. Calcein Staining

To evaluate craniofacial structure formation in zebrafish, fertilized one-cell wild-type AB embryos were injected with best1-MO and control-MO. At 6-dpf, zebrafish were washed with fish water 3 times and immersed in 0.2% Calcein solution for 10 minutes. Then, zebrafish were rinsed thoroughly in fish water 3 times (5 minutes for each time) and anaesthetized with 0.016% MS-222 (tricaine methanesulfonate, Sigma-Aldrich). Zebrafish were then oriented on lateral side and ventral side, and mounted with 3% methylcellulose (Sigma-Aldrich) in a depression slide for observation by fluorescence microscopy.

5. Image Acquisition

Embryos and larvae were analyzed with Nikon SMZ 18 Fluorescence microscope and subsequently photographed with digital cameras. A subset of images was adjusted for levels, brightness, contrast, hue and saturation with Adobe Photoshop 7.0 software (Adobe, San Jose, CA, USA) to optimally visualize the expression patterns. Quantitative image analyses were processed using image based morphometric analysis (NIS-Elements D4.6, Nikon, Tokyo, Japan) and ImageJ software (U.S. National Institutes of Health, Bethesda, MD, USA; http://rsbweb.nih.gov/ij/). 10 animals were including in group and average signal per animal was calculated.

6. Statistical Analysis

All data are presented as mean ± standard error of the mean (SEM). Statistical analysis and graphical representation of the data were performed using GraphPad Prism 5.0 (GraphPad Software, San Diego, CA, USA). Statistical significance was performed using a Student t-test, analysis of variance or χ2 test as appropriate.


1. Effectiveness of best1 I3E4-MO

Customized MOs were microinjected into one-cell stage embryos (Supplementary Fig. 1A). Two specific antisense MOs targeting zebrafish best1 gene were designed to prevent either the translation of best1 mRNA (ATG-MO) or proper splicing of intron3 and exon4 (I3E4-MO) of best1 pre-mRNA (Supplementary Fig. 1B). We confirmed that I3E4-MO prevented proper splicing of intron3 at 30-hpf by RT-PCR. The additional band indicated that the splicing between intron 3 and exon 4 was altered with inserting part of intron3 (Supplementary Fig. 1C, lane 2). In addition, the expression of house-keeping genes ef1α was not influenced by both control-MO and I3E4-MO (Supplementary Fig. 1C, lanes 5 and 6). The expression level of wildtype best1 mRNA in I3E4-MO injected embryos was significantly lower than that of the control (p < 0.0001; Supplementary Fig. 1D) with quantitative RT-PCR. This demonstrated the efficacy of I3E4-MO to knocked down best1 gene.

2. Knockdown of best1 Causes Potent Developmental Defects in Zebrafish

We used transgenic (Tg) zebrafish (HuC: EGFP transgenic line) to observe the phenotypes of zebrafish embryos after best1 knockdown by injection of ATG-MO and I3E4-MO. To increase the objectivity of the measurements, we performed the quantification process in a blinded manner. This approach concealed the experimental groups during the measurement procedure, avoiding potential bias in the evaluation of phenotypic changes. Compared to control-MO injected embryos (Fig. 1A and B), both I3E4-MO injected (Fig. 1C and D) and ATG-MO injected (Fig. 1E and F) embryos exhibited significantly reduced body length (p < 0.0001) (Fig. 1G) and apparent curved body axis (p < 0.0001) (Fig. 1D, F, and H; Supplementary Fig. 2). The survival rate of best1 knockdown embryos was decreased (Fig. 1I) and the percentage of live embryos with aforementioned gross defects was significantly higher in the best1 knockdown group versus the control group (p < 0.0001) (Fig. 1J).
Knockdown of best1 caused several developmental abnormalities in the nervous system, including defects in head and brain patterning (Fig. 2A, E, and I, denoted by dotted lines and blue arrowheads) and defective neuronal outgrowth (Fig. 2B, F, and J, arrows in control embryo indicate normal motor axons; asterisks in I3E4-MO and ATG-MO embryos showed no outgrowth of axons). Quantitative morphometric analysis revealed substantially decreased head and brain sizes (p < 0.0001) (Fig. 2M and N) and markedly shortened motor neuron length (p < 0.0001) (Fig. 2O) in I3E4-MO embryos compared to controls. Knockdown of best1 also resulted in reduced eye size of zebrafish (Fig. 2E and I, marked by black arrowheads).
Taken together, these results demonstrate that the knockdown of best1 in zebrafish embryos can lead to shorter body length, curved body axis, low survival rate, microcephaly, small eyes, reduced head and brain size, and impaired neuronal outgrowth.

3. Knockdown of best1 Causes Craniofacial and Vertebral Skeletal Ossification Defect

By application of the fluorescent dye Calcein to label the calcified matrix of the skeleton, a significant reduction of craniofacial skeletal ossification was found in best1 knockdown zebrafish (6 days post fertilization, 6 dpf) compared to that of control (Fig. 3). In the control embryos, 5 pairs of craniofacial bone structures were nicely labeled in both lateral (Fig. 3A and D) and ventral (Fig. 3G and J). However, only the fifth branchial arch (5ba) was faintly labeled in the I3E4-MO embryos (Fig. 3B, E, H, and K), and no calcified bone structures were identified in the ATG-MO embryos (Fig. 3C, F, I, and L). Impaired craniofacial development also led to increased interorbital distance in best1 knockdown embryos (p < 0.0001) (Fig. 3MO).
Furthermore, we administrated Calcein at 8.5 dpf to visualize calcified vertebrae of zebrafish embryos. On average, 14 vertebral segments could be clearly identified in the control group (Fig. 4AC). Whereas zero vertebrae could be distinguished in best1 knockdown embryos (Fig. 4DH). There is a significant difference among the groups (p < 0.0001) (Fig. 4I).
These findings indicated that best1 might play a critical role in the early skeletal development of zebrafish.


Congenital CVJ skeletal malformation is a rare disease that can lead to disastrous neurological deficits in patients. The etiology of congenital CVJ malformation is still undefined. In our previous study, 5 loss-of-function or damaging missense were detected out of 92 congenital CVJ skeletal malformation patients (carrier rate = 5.43%), which is significantly enriched in the patient group compared with in-house control (p = 5.77×10–6; odds ratio, 27.74; 95% confidence interval, 7.15–94.25) [13]. In this study, we designed MOs targeting zebrafish best1 to knockdown best1 expression and investigated the corresponding phenotypes.
First, the knockdown of best1 in zebrafish embryos caused smaller eyes than control. Microphthalmia (axial length≤20 mm) has been reported in multiple VMD2 patients [24,25]. It has been reported that BEST1 played an essential role in ocular patterning, maintenance of retinal pigment epithelium (RPE) cells, and normal growth of the eye [26]. Bestrophin is a 585 amino acid transmembrane protein acting as an oligomeric chloride channel that regulates calcium channels for calcium and transmembrane potential homeostasis [27]. Bestrophin mutations alter chloride ion-related conductance across the RPE cell membrane, and abnormal channel function may account for the abnormal electro-oculogram seen in patients with Best disease. Our results in zebrafish agreed with that in VMD2 patients.
Second, the knockdown of best1 in zebrafish embryos resulted in multiple skeletal defects, including shorter body length, curved body axis, microcephaly, and impaired ossification of craniofacial and vertebral bone. Early zebrafish skeleton patterning is regulated by complex signaling pathways, including hox, fgf, shh, tbx, hmx, runx2, bmp, and others [28,29]. Intriguingly, skeleton malformations can be associated with eye and ear disorders. In human Oculoauricular Syndrome (MIM 612109), patients manifest with complex ocular anomalies, including microphthalmia, dysplastic ears with abnormal external ear cartilage, as well as spina bifida occulta and platybasia [30]. In mice, mutations in Mitf gene can cause microphthalmia, deafness and osteopetrosis [31]. BEST1 is regulated by MITF [32], these results imply that BEST1 gene plays an important role in eye development and skeletal ossification. In addition, BEST1 interacts with ANO6, another calcium-dependent transmembrane channel, which is crucial for apatite deposition in bone mineralization [33]. ANO6 activates NCX1, a calcium channel in osteoblasts, to transport calcium to the extracellular matrix for bone formation. Ano6-/- mouse embryos (E15.5) also show delayed bone mineralization [34], which is highly consistent with our zebrafish results.
Third, best1 knockdown caused microcephaly, reduced brain size, and impaired neuronal outgrowth in zebrafish embryos. Woo et al. [16] prepared Best1 knockout mice to investigate tonic inhibition in the brain and found that inhibition of Best1 resulted in enhanced neuronal excitability in the cerebellum. Apparently Bestrophins distribute and function as ion channels in the central nervous system [27]. However, no studies have yet reported these neurological developmental defects.
Intriguingly, the patient in our cohort with a premature stop codon of BEST1 gene (p.S79Ffs*153) did present with ophthalmic, spinal and neurological developmental defects (Fig. 5). This is a 27-year-old female patient suffering with decreased sensation on all limbs and weakness of bilateral lower limbs for one year. Physical examination revealed increased tendon reflexes and positive Hoffmann and Babinski signs. Imaging workup found Chiari malformation with syringomyelia and hydrocephalus, multiple spinal anomalies (including assimilation of atlas, basilar invagination, fusion of C5 and C6 vertebrae, butterfly vertebra at T12 and scoliosis) and microphthalmia. She denied decreased visual acuity, which is a later-onset symptom of VMD2, and refused a fundus examination. The specific genetic mutation identified in the patient was a premature stop codon, which could result in truncation of the Bestrophin-1 protein, affecting its normal structure and function. Interestingly, this mutation’s impact in humans is similar to that of MO, which knocks down the expression of the best1 gene in zebrafish. Notably, this premature stop codon mutation was identified in a CVJ malformation patient who also presented comorbidities such as microphthalmia, neurological defects, and multiple skeletal malformations, particularly along the spine. Given the homology between zebrafish and humans, it is hypothesized that decreased BEST1 gene function, whether due to a premature stop codon in humans or through MO knockdown in zebrafish, could disrupt critical molecular pathways related to eye, neurological, and skeletal development, leading to similar phenotypes. Further research is required to investigate these mechanisms.
Our study has several limitations. First, the VMD2 manifests with later-onset macular/retinal dystrophy. Thus, we did not examine the retina of zebrafish embryos for macular dystrophy. Second, this is an in vivo knockdown study that validated the essential role of the best1 gene in the early development of zebrafish. Further knockout studies and in vitro experiments are warranted to delineate upstream and downstream targets and pathways involved. Third, the CVJ structures of zebrafish are not as analogical to humans compared with that of mice, which may be more suitable for our future study.


Damaging mutation of BEST1 gene may cause a subtype of CVJ malformation with comorbidities such as microphthalmia, VMD2, spinal anomalies, scoliosis, and neurological defects. Further studies are required to investigate the mechanism and possible preventive measures for the subtype of CVJ malformation.

Supplementary Materials

Supplementary Table 1 and Figs. 1-2 can be found via https://doi.org/10.14245/ns.2347238.619.
Supplementary Table 1.
Primer sequences quantitative real-time polymerase chain reaction
Supplementary Fig. 1.
Morpholino (MO)-targeted down-regulation of best1 was confirmed by reverse transcription-polymerase chain reaction (RT-PCR) and quantitative RT-PCR (qRT-PCR). (A) Four nonogram of each type of MOs were microinjected into fertilized one-cell stage embryos according to standard protocols. (B) The zebrafish best1 gene was targeted by specific morpholino antisense to prevent start of expression (ATG-MO) or proper splicing of exon 4 (I3E4-MO). Primers 3F and 6R interrogate the presence of wild-type (nonmutant) transcripts or those in which intron 3 has been inserted. (C) RT-PCR of best1 transcript from control-MO and I3E4-MO morpholino-injected embryos 30-hpf, demonstrating insertion of intron3. Injection of 4 ng of best1 morpholino alters the splicing between intron 3 and exon 4, as revealed by shift in PCR bands between control and best1 morpholino-injected embryos. (D) Quantitative measurements of best1 expression levels measured by qRT-PCR (***p < 0.0001). Samples were collected at 30-hpf after introduction of 4 ng of MO at the one-cell stage (N = 30). hpf, hours post fertilization.
Supplementary Fig. 2.
Reduced body length and apparent curved body axis in I3E4-MO (B, E) and ATG-MO (C, F) injected embryos compared with control-MO injected embryos (A, D).


Conflict of Interest

The authors have nothing to disclose.


This research was funded by the National High Level Hospital Clinical Research Funding (2022-PUMCH-D-004).

Author Contribution

Conceptualization: ZL, FJ, HWu; Data curation: ZL, KL, KW, LZ, SJ, HWang, FJ, HWu; Formal analysis: ZL, KL, KW, LZ; Funding acquisition: HWu; Methodology: ZL, KL, KW, LZ, SJ, HWang, FJ, HWu; Project administration: ZL, FJ, HWu; Visualization: SJ, HWang; Writing – original draft: ZL, KL; Writing – review & editing: ZL, KL, FJ, HWu.

Fig. 1.
Body length, body axis and survival rate of best1 zebrafish morphants. (A–F) Gross morphology of transgenic (HuC:EGFP) zebrafish embryos at 2-dpf. Compared with control morpholino (MO), knock down best1 causes shorter body length (C–F), curved body axis (C–F). (G) A time-course plot of percent survival in control versus best1 morphants for 3 days. (H) The percentage of embryos with development defects. (I, J) Quantification of body length (I) and curvature angles (J) of embryos. Columns, mean; standard error of the mean (n = 10; analysis of variance), ***p < 0.0001. Scale bar, 100 μm. dpf, days post fertilization.
Fig. 2.
Nervous system developmental abnormalities caused by best1 knockdown. (A–L) Gross morphology of transgenic (HuC:EGFP) zebrafish embryos at 2-dpf. Compared with control morpholino (MO), knockdown of best1 gene causes head and brain patterning defects (E, I, blue arrowheads), microcephaly (E, I, yellow dotted line), small eyes (E, I, black arrowheads), brain-size reductions (F, J, H, and L), and abnormal neuronal outgrowth (F, J, asterisks). (M–O) Quantification of the head area (M), brain area (N) and average motor axon length (O) shows significantly decrease in best1 morphants. Columns, mean; standard error of the mean (n=10; analysis of variance), ***p < 0.0001. Scale bar, 100 μm. dpf, days post fertilization.
Fig. 3.
Loss of best1 causes abnormal craniofacial structure and interorbital distance. (A–N) Representative bright field and fluorescent images of zebrafish head skeleton at 6-dpf. In vivo visualization of the skeleton is achieved by the administration of a fluorescent dye (Calcein) directly to the fish water. Dyes that bind to calcified matrix can be used to label the entire skeleton. Lateral view (A–F) and ventral view (G–L) of the head skeleton of day-6 embryos labeled with Calcein. (B, C, E, F, H, I, K, and L) When embryos were injected with best1-morpholino (MO) at the one-cell stage, the amount of stained mineralized tissue was significantly reduced compared to fish injected with control-MO. Panel N show increased intraocular distance (yellow arrows) in best1 morphants. Panel M and N show measurements of the distance between the eyes, and panel O shows the distances depicted graphically as the mean for 10 embryos of each type. Columns, mean; standard error of the mean (n = 10; analysis of variance), ***p < 0.0001. Scale bar, 100 μm. 5ba, fifth branchial arch; op, opercular bone; ec, ectopterygoid; e, ethmoid plate; pq, palatoquadrate; m, Meckel cartilage; dpf, days postfertilization.
Fig. 4.
Loss of best1 causes abnormal craniofacial structure and vertebral development. (A–H) Representative bright field and fluorescent images of zebrafish skeleton at 8.5-dpf. In vivo visualization of the skeleton is achieved by the administration of a fluorescent dye (Calcein) directly to the fish water. Dyes that bind to calcified matrix can be used to label the entire skeleton. Lateral view (B, C) of the skeleton and mineralized vertebrae of day-8.5 embryos labeled with Calcein. Vertebrae 1, 2, 3, 4, 5, and 6 are indicated. (E, F, and H) When embryos injected with best1-morpholino (MO) at one-cell stage, the amount of stained mineralized tissue is markedly reduced compared to control-MO-injected fish. Vertebral development is significantly delayed in best1 morphants. (I) Quantification of the number of mineralized vertebrae at 8.5-dpf. Columns, mean; standard error of the mean (n = 10; analysis of variance), ***p < 0.0001. Scale bar, 100 μm. dpf, days postfertilization.
Fig. 5.
phenotypes of the patient with a premature stop codon of BEST1 gene (p.S79Ffs*153). (A–C) Sagittal magnetic resonance imaging (MRI) revealed Chiari malformation (cerebellar tonsil exceeding the foramen magnum, yellow line) and extensive syringomyelia (red stars) at cervical and thoracic segments. (D–G) Computed tomography and x-ray showed assimilation of atlas (arrow), basilar invagination (odontoid process above the chamberlian line, yellow dotted line), Klippel-Feil malformation (fusion of C5 and C6 vertebrae), butterfly vertebra at T12 (arrow head) and scoliosis. (H, I) MRI of the head indicated hydrocephalus (&) and microphthalmia (diameter of eyeball is smaller than 20 mm).


1. Offiah CE, Day E. The craniocervical junction: embryology, anatomy, biomechanics and imaging in blunt trauma. Insights Imaging 2017;8:29-47.
crossref pmid pmc pdf
2. Pang D, Thompson DNP. Embryology, classification, and surgical management of bony malformations of the craniovertebral junction. Adv Tech Stand Neurosurg 2014;40:19-109.
crossref pmid
3. Jian FZ, Chen Z, Wrede KH, et al. Direct posterior reduction and fixation for the treatment of basilar invagination with atlantoaxial dislocation. Neurosurgery 2010;66:678-87. discussion 687.
crossref pmid pdf
4. Sharma DK, Sharma D, Sharma V. Atlantooccipital fusion: prevalence and its developmental and clinical correlation. J Clin Diagn Res 2017;11:AC01-3.
crossref pmid pmc
5. Condie BG, Capecchi MR. Mice homozygous for a targeted disruption of Hoxd-3 (Hox-4. 1) exhibit anterior transformations of the first and second cervical vertebrae, the atlas and the axis. Development 1993;119:579-95.
crossref pmid pdf
6. Cremers MJ, Bol E, de Roos F, et al. Risk of sports activities in children with Down’s syndrome and atlantoaxial instability. Lancet 1993;342:511-4.
crossref pmid
7. Hankinson TC, Anderson RCE. Craniovertebral junction abnormalities in Down syndrome. Neurosurgery 2010;66(3 Suppl):32-8.
crossref pmid pdf
8. Menezes AH. Specific entities affecting the craniocervical region: Down’s syndrome. Childs Nerv Syst 2008;24:1165-8.
crossref pmid pdf
9. Williams N, Narducci A, Eastwood DM, et al. An evidence-based approach to the management of children with morquio a syndrome presenting with craniocervical pathology. Spine (Phila Pa 1976) 2018;43:E1443-53.
crossref pmid
10. Giangiobbe S, Caraffi SG, Ivanovski I, et al. Expanding the phenotype of WIEDEMANN‐STEINER syndrome: craniovertebral junction anomalies. Am J Med Genet 2020;182:2877-86.
11. Sadler B, Wilborn J, Antunes L, et al. Rare and de novo coding variants in chromodomain genes in Chiari I malformation. Am J Hum Genet 2021;108:100-14.
crossref pmid pmc
12. Chauhan AK, Chandra PS, Goyal N, et al. Weak ligaments and sloping joints: a new hypothesis for development of congenital atlantoaxial dislocation and basilar invagination. Neurospine 2020;17:843-56.
pmid pmc
13. Liu Z, Du H, Zhao H, et al. Dissection of mendelian predisposition and complex genetic architecture of craniovertebral junction malformation. Human Genetics 2023;142:89-101.
crossref pmid pdf
14. Marquardt A, Stöhr H, Passmore LA, et al. Mutations in a novel gene, VMD2, encoding a protein of unknown properties cause juvenile-onset vitelliform macular dystrophy (Best’s disease). Hum Mol Genet 1998;7:1517-25.
crossref pmid
15. Schatz P, Klar J, Andréasson S, et al. Variant phenotype of best vitelliform macular dystrophy associated with compound heterozygous mutations in VMD2. Ophthalmic Genet 2006;27:51-6.
crossref pmid
16. Woo J, Min JO, Kang DS, et al. Control of motor coordination by astrocytic tonic GABA release through modulation of excitation/inhibition balance in cerebellum. Proc Natl Acad Sci USA 2018;115:5004-9.
crossref pmid pmc
17. Valenti MT, Marchetto G, Mottes M, et al. Zebrafish: a suitable tool for the study of cell signaling in bone. Cells 2020;9:1911.
crossref pmid pmc
18. Tonelli F, Bek JW, Besio R, et al. Zebrafish: a resourceful vertebrate model to investigate skeletal disorders. Front Endocrinol 2020;11:489.
crossref pmid pmc
19. Sun X, Zhou Y, Zhang R, et al. Dstyk mutation leads to congenital scoliosis-like vertebral malformations in zebrafish via dysregulated mTORC1/TFEB pathway. Nat Commun 2020;11:479.
crossref pmid pmc pdf
20. Westerfield M. The zebrafish book. A guide for the laboratory use of zebrafish (Danio rerio). 4th ed. Eugene (OR): Univ. of Oregon Press; 2000.

21. Kimmel CB, Ballard WW, Kimmel SR, et al. Stages of embryonic development of the zebrafish. Dev Dyn 1995;203:253-310.
crossref pmid
22. Park HC, Kim CH, Bae YK, et al. Analysis of upstream elements in the HuC promoter leads to the establishment of transgenic zebrafish with fluorescent neurons. Dev Biol 2000;227:279-93.
crossref pmid
23. Nasevicius A, Ekker SC. Effective targeted gene “knockdown” in zebrafish. Nat Genet 2000;26:216-20.
crossref pmid pdf
24. Wittström E, Ponjavic V, Bondeson ML, et al. Anterior segment abnormalities and angle-closure glaucoma in a family with a mutation in the BEST1 gene and best vitelliform macular dystrophy. Ophthalmic Genet 2011;32:217-27.
crossref pmid
25. Shi J, Sun T, Xu K, et al. Variants of BEST1 and CRYBB2 cause a complex ocular phenotype comprising microphthalmia, microcornea, cataract, and vitelliform macular dystrophy: case report. BMC Ophthalmol 2023;23:165.
crossref pmid pmc pdf
26. Yardley J, Leroy BP, Hart-Holden N, et al. Mutations of VMD2 splicing regulators cause nanophthalmos and autosomal dominant vitreoretinochoroidopathy (ADVIRC). Invest Ophthalmol Vis Sci 2004;45:3683-9.
crossref pmid
27. Kane Dickson V, Pedi L, Long SB. Structure and insights into the function of a Ca2+-activated Cl− channel. Nature 2014;516:213-8.
crossref pmid pmc pdf
28. Dietrich K, Fiedler IA, Kurzyukova A, et al. Skeletal biology and disease modeling in Zebrafish. J Bone Miner Res 2021;36:436-58.
crossref pmid pdf
29. El Fersioui Y, Pinton G, Allaman-Pillet N, et al. Premature vertebral mineralization in hmx1-mutant zebrafish. Cells 2022;11:1088.
crossref pmid pmc
30. Schorderet DF, Nichini O, Boisset G, et al. Mutation in the human homeobox gene NKX5-3 causes an Oculo-Auricular Syndrome. Am J Hum Genet 2008;82:1178-84.
crossref pmid pmc
31. Steingrímsson E, Moore KJ, Lamoreux ML, et al. Molecular basis of mouse microphthalmia (mi) mutations helps explain their developmental and phenotypic consequences. Nat Genet 1994;8:256-63.
crossref pmid pdf
32. Esumi N, Kachi S, Campochiaro PA, et al. VMD2 promoter requires two proximal E-box sites for its activity in vivo and is regulated by the MITF-TFE family. J Biol Chem 2007;282:1838-50.
crossref pmid
33. Ousingsawat J, Wanitchakool P, Schreiber R, et al. Anoctamin-6 controls bone mineralization by activating the calcium transporter NCX1. J Biol Chem 2015;290:6270-80.
crossref pmid pmc
34. Ehlen HW, Chinenkova M, Moser M, et al. Inactivation of anoctamin-6/Tmem16f, a regulator of phosphatidylserine scrambling in osteoblasts, leads to decreased mineral deposition in skeletal tissues. J Bone Miner Res 2013;28:246-59.
crossref pmid pdf

Editorial Office
CHA University, CHA School of Medicine Bundang Medical Center
59 Yatap-ro, Bundang-gu, Seongnam-si, Gyeonggi-do 13496, Korea
Tel: +82-31-780-1924  Fax: +82-31-780-5269  E-mail: support@e-neurospine.org
The Korean Spinal Neurosurgery Society
#407, Dong-A Villate 2nd Town, 350 Seocho-daero, Seocho-gu, Seoul 06631, Korea
Tel: +82-2-585-5455  Fax: +82-2-2-523-6812  E-mail: ksns1987@gmail.com
Business License No.: 209-82-62443

Copyright © The Korean Spinal Neurosurgery Society.

Developed in M2PI

Zoom in Close layer